Covaxin Maker Gets $19 Million For Development Of 'Variant Proof' Vaccine

CEPI on Tuesday said it will provide up to USD 19.3 million (about Rs 149 crore) to Bharat Biotech International, the University of Sydney, and Switzerland-based ExcellGene SA for the development of a...

from NDTV News - Special https://ift.tt/HAad5FK

Comments

Popular posts from this blog

Watch: IndiGo Pilot Cheers For "The Elephant Whisperers" Stars Bomman, Bellie

TikTok Working on Parental Control Tool to Restrict Content for Teens Amid Growing Scrutiny

Viral Video Shows 3,000 Engineers Queuing Up For Job Interview In Pune